New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 29, 2014
08:03 EDTSTAASTAAR Surgical has upside potential following solid yearly start, says Canaccord
Canaccord remains bullish on STAAR Surgical citing its solid start to 2014 and sum of the parts methodology. The firm sees a number of catalysts including gross margin expansion, revenue growth acceleration, and potential for raised guidance. Shares are Buy rated and price target increased to $21 from $20.
News For STAA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
06:33 EDTSTAASTAAR Surgical appoints Caren Mason as CEO
STAAR Surgical has named Caren Mason president and CEO effective immediately. Mason, who was elected to STAAR's board in June 2014, and was appointed by the board to chair the Quality and Regulatory Committee in September 2014, replaces Barry Caldwell who retired as of March 1. Mason joins STAAR after most recently serving as CEO of, and then advisor to, Verinta Health.
February 25, 2015
16:11 EDTSTAASTAAR Surgical reports Q4 EPS (3c), consensus (5c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use